Julia Stingl

34PUBLICATIONS
107CO-AUTHORS
PharmacogenomicsCheminformatics and quantitative structure-activity relationshipsMolecular targetsMolecular medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 02, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

|Feb 21, 2026
The quantitative impact of metabolism-inhibiting drugs on the occurrence of adverse drug reactions-A backward selection approach.

Judith Berres, Justyna Wozniak, Hannah Fölsch

|Jun 24, 2025
Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study.

Henk-Jan Guchelaar, Cathelijne H van der Wouden, Lisanne E N Manson

|May 28, 2025
Genomewide association analysis on green tea chemoprevention of colorectal adenoma: the importance of SLCO1A2 variants.

J Stingl, C Scholl, M Steffens

|Feb 17, 2025
Solanidine-derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients.

Jens Andreas Sarömba, Julian Peter Müller, Jolanta Tupiec

|Jan 10, 2025
Pharmacogenetic guided drug therapy - how to deal with phenoconversion in polypharmacy.

Julia Carolin Stingl, Roberto Viviani

Pageof 6

Frequent Collaborators

9 joint publications

Katja Susanne Just

3 joint publications

Bernhardt Sachs

3 joint publications

Roberto Viviani

3 joint publications

Diana Dubrall